London-based AstraZeneca is using MicroStrategy to report on and analyze data in its sales
prescriber data warehouse (SPW). Approximately 250 employees use MicroStrategy’s Webbased
analytical tools to determine market share, easily explore cost and profit data, and
track the performance of new products. As a result, employees are making more effective
business decisions that increase sales and drive market share gains.
The global pharmaceutical company uses the MicroStrategy platform to distribute 70,000
reports within a 24-hour window each month. AstraZeneca employees can pull up reports
through its sales force portal or run queries — with 20-second average response times — against
a one-terabyte Oracle® data warehouse. As a result, end users can view critical pharmaceutical
sales information in a matter of seconds and quickly make decisions that seek to optimize
market share with a particular HMO or prescription benefit management organization.
“MicroStrategy business intelligence gives us a better understanding of the market, and
helps us meet expected market share goals for our products,” said Keith Megay, Senior
Manager of Commercial Data Warehousing at AstraZeneca. “In addition, the performance
and scalability of our MicroStrategy-based application is remarkable, allowing our users to
be more productive and efficient.”
AstraZeneca is a major international healthcare business engaged in the research, development,
manufacture, and marketing of prescription pharmaceuticals and the supply of healthcare services.
It is one of the world’s leading pharmaceutical companies with healthcare sales of $26.47
billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory,
oncology, and infection products.
Using High Volume Reporting to Make Informed Sales
and Pricing Decisions